Green nanotech paradigm for enhancing sesquiterpene lactone therapeutics in cancer

Research output: Contribution to journalReview articlepeer-review


In the field of cancer therapy, sesquiterpene lactones (SLs) derived from diverse Dicoma species demonstrate noteworthy bioactivity. However, the translation of their full therapeutic potential into clinical applications encounters significant challenges, primarily related to solubility, bioavailability, and precise drug targeting. Despite these obstacles, our comprehensive review introduces an innovative paradigm shift that integrates the inherent therapeutic properties of SLs with the principles of green nanotechnology. To overcome issues of solubility, bioavailability, and targeted drug delivery, eco-friendly strategies are proposed for synthesizing nanocarriers. Green nanotechnology has emerged as a focal point in addressing environmental and health concerns linked to conventional treatments. This progressive approach of green nanotechnology holds promise for the development of safe and sustainable nanomaterials, particularly in the field of drug delivery. This groundbreaking methodology signifies a pioneering advancement in the creation of novel and effective anticancer therapeutics. It holds substantial potential for transforming cancer treatment and advancing the landscape of natural product research.

Original languageEnglish
Article number116426
JournalBiomedicine and Pharmacotherapy
Publication statusPublished - Apr 2024


  • Anticancer therapy
  • Bioactive compounds
  • Dicoma species
  • Green nanotechnology
  • Sesquiterpene lactones

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Green nanotech paradigm for enhancing sesquiterpene lactone therapeutics in cancer'. Together they form a unique fingerprint.

Cite this